2 results
Approved WMOCompleted
1) To evaluate the safety and tolerability of MLT*s npMNAs2) To evaluate the pharmacokinetics of intradermal desmopressin administration via MLT*s npMNAs
Approved WMOPending
Primary Objective: To assess the safety of long-term administration of KVD900 in adolescent and adult patients with HAE type I or II.Secondary Objectives: • To assess the long-term efficacy of KVD900 in the treatment of attacks in adolescent and…